|
PDSS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.681400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.357000E-01 |
| Normal-vs-Stage2 |
7.229400E-01 |
| Normal-vs-Stage3 |
3.239200E-01 |
| Normal-vs-Stage4 |
5.101700E-02 |
| Stage1-vs-Stage2 |
7.834000E-01 |
| Stage1-vs-Stage3 |
1.886630E-01 |
| Stage1-vs-Stage4 |
5.830500E-02 |
| Stage2-vs-Stage3 |
2.785200E-01 |
| Stage2-vs-Stage4 |
6.228300E-02 |
| Stage3-vs-Stage4 |
4.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.376400E-01 |
| Normal-vs-AfricanAmerican |
2.303800E-01 |
| Normal-vs-Asian |
5.669200E-01 |
| Caucasian-vs-AfricanAmerican |
3.966300E-02 |
| Caucasian-vs-Asian |
5.454000E-01 |
| AfricanAmerican-vs-Asian |
9.014600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.051400E-01 |
| Normal-vs-Female |
8.521400E-01 |
| Male-vs-Female |
6.771400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.468000E-01 |
| Normal-vs-Extreme_Weight |
8.940400E-01 |
| Normal-vs-Obese |
6.093600E-01 |
| Normal-vs-Extreme_Obese |
5.933000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.242000E-01 |
| Normal_Weight-vs-Obese |
5.814600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.145400E-01 |
| Extreme_Weight-vs-Obese |
6.627200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.567400E-01 |
| Obese-vs-Extreme_Obese |
4.750400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.260400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.677200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.865600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.358600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.552000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.642600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.922600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.090200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.225800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.931600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.176200E-01 |
| Normal-VS-Type2 PRCC |
5.419800E-02 |
| Normal-VS-KIRP CIMP |
4.760400E-02 |
| Normal-VS-Unclassified PRCC |
5.854200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.239300E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.437980E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.095200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.238400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.039600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.730210E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.133200E-01 |
| Normal-vs-N1 |
5.664800E-01 |
| Normal-vs-N2 |
3.373200E-01 |
| N0-vs-N1 |
8.605000E-01 |
| N0-vs-N2 |
3.337800E-01 |
| N1-vs-N2 |
2.877600E-01 |
|
|
